238 related articles for article (PubMed ID: 23262837)
1. The shifting landscape of metastatic breast cancer to the CNS.
Quigley MR; Fukui O; Chew B; Bhatia S; Karlovits S
Neurosurg Rev; 2013 Jul; 36(3):377-82. PubMed ID: 23262837
[TBL] [Abstract][Full Text] [Related]
2. Treatment and prognosis of leptomeningeal disease secondary to metastatic breast cancer: A single-centre experience.
Kingston B; Kayhanian H; Brooks C; Cox N; Chaabouni N; Redana S; Kalaitzaki E; Smith I; O'Brien M; Johnston S; Parton M; Noble J; Stanway S; Ring A; Turner N; Okines A
Breast; 2017 Dec; 36():54-59. PubMed ID: 28968585
[TBL] [Abstract][Full Text] [Related]
3. Luminal subtypes predict improved survival following central nervous system metastasis in patients with surgically managed metastatic breast carcinoma.
Wiens AL; Martin SE; Bertsch EC; Vance GH; Stohler RA; Cheng L; Badve S; Hattab EM
Arch Pathol Lab Med; 2014 Feb; 138(2):175-81. PubMed ID: 24476516
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological and Treatment-Associated Prognostic Factors in Patients with Breast Cancer Leptomeningeal Metastases in Relation to Tumor Biology.
Griguolo G; Pouderoux S; Dieci MV; Jacot W; Bourgier C; Miglietta F; Firmin N; Conte P; Viala M; Guarneri V; Darlix A
Oncologist; 2018 Nov; 23(11):1289-1299. PubMed ID: 30120164
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with overall survival in breast cancer patients with leptomeningeal disease (LMD): a single institutional retrospective review.
Wallace G; Kundalia R; Vallebuona E; Cao B; Kim Y; Forsyth P; Soyano A; Smalley I; Pina Y
Breast Cancer Res; 2024 Mar; 26(1):55. PubMed ID: 38553702
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic characteristics and prognostic factors in 420 metastatic breast cancer patients with central nervous system metastasis.
Altundag K; Bondy ML; Mirza NQ; Kau SW; Broglio K; Hortobagyi GN; Rivera E
Cancer; 2007 Dec; 110(12):2640-7. PubMed ID: 17960791
[TBL] [Abstract][Full Text] [Related]
7. Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases.
Lin NU; Claus E; Sohl J; Razzak AR; Arnaout A; Winer EP
Cancer; 2008 Nov; 113(10):2638-45. PubMed ID: 18833576
[TBL] [Abstract][Full Text] [Related]
8. Metastatic breast cancer subtypes and central nervous system metastases.
Aversa C; Rossi V; Geuna E; Martinello R; Milani A; Redana S; Valabrega G; Aglietta M; Montemurro F
Breast; 2014 Oct; 23(5):623-8. PubMed ID: 24993072
[TBL] [Abstract][Full Text] [Related]
9. Central Nervous System Metastasis in Patients with HER2-Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival from SystHERs.
Hurvitz SA; O'Shaughnessy J; Mason G; Yardley DA; Jahanzeb M; Brufsky A; Rugo HS; Swain SM; Kaufman PA; Tripathy D; Chu L; Li H; Antao V; Cobleigh M
Clin Cancer Res; 2019 Apr; 25(8):2433-2441. PubMed ID: 30593513
[TBL] [Abstract][Full Text] [Related]
10. Central nervous system metastases in breast cancer: the impact of age on patterns of development and outcome.
Ben-Zion Berliner M; Yerushalmi R; Lavie I; Benouaich-Amiel A; Tsoref D; Hendler D; Goldvaser H; Sarfaty M; Rotem O; Ulitsky O; Siegal T; Neiman V; Yust-Katz S
Breast Cancer Res Treat; 2021 Jan; 185(2):423-432. PubMed ID: 33037977
[TBL] [Abstract][Full Text] [Related]
11. Central nervous system metastases in breast cancer patients with germline BRCA pathogenic variants compared to non-carriers: a matched-pair analysis.
Ben-Zion Berliner M; Yust-Katz S; Lavie I; Goldberg Y; Kedar I; Yerushalmi R
BMC Cancer; 2024 Feb; 24(1):219. PubMed ID: 38365640
[TBL] [Abstract][Full Text] [Related]
12. Characteristics and Outcomes of Patients With Breast Cancer With Leptomeningeal Metastasis.
Morikawa A; Jordan L; Rozner R; Patil S; Boire A; Pentsova E; Seidman AD
Clin Breast Cancer; 2017 Feb; 17(1):23-28. PubMed ID: 27569275
[TBL] [Abstract][Full Text] [Related]
13. Defining prognosis for women with breast cancer and CNS metastases by HER2 status.
Dawood S; Broglio K; Esteva FJ; Ibrahim NK; Kau SW; Islam R; Aldape KD; Yu TK; Hortobagyi GN; Gonzalez-Angulo AM
Ann Oncol; 2008 Jul; 19(7):1242-1248. PubMed ID: 18334512
[TBL] [Abstract][Full Text] [Related]
14. Central nervous system metastases in patients with high-risk breast carcinoma after multimodality treatment.
Gonzalez-Angulo AM; Cristofanilli M; Strom EA; Buzdar AU; Kau SW; Broglio KR; Smith TL; Hortobagyi GN
Cancer; 2004 Oct; 101(8):1760-6. PubMed ID: 15386311
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcome of central nervous system metastases from breast cancer: differences in survival depending on systemic treatment.
Kim HJ; Im SA; Keam B; Kim YJ; Han SW; Kim TM; Oh DY; Kim JH; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Noh DY; Heo DS; Park IA; Bang YJ; Ha SW
J Neurooncol; 2012 Jan; 106(2):303-13. PubMed ID: 21938531
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes and treatment practice patterns of patients with HER2-positive metastatic breast cancer in the post-trastuzumab era.
Olson EM; Najita JS; Sohl J; Arnaout A; Burstein HJ; Winer EP; Lin NU
Breast; 2013 Aug; 22(4):525-31. PubMed ID: 23352568
[TBL] [Abstract][Full Text] [Related]
17. Central nervous system metastases in a cohort of metastatic breast cancer patients treated with trastuzumab.
Montagna E; Cancello G; D'Agostino D; Lauria R; Forestieri V; Esposito A; Silvestro L; Accurso A; De Placido S; De Laurentiis M
Cancer Chemother Pharmacol; 2009 Jan; 63(2):275-80. PubMed ID: 18379783
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic factors for non-small cell lung cancer patients with central nervous system metastasis with positive driver genes].
Li R; Zhang SR; Liu XF; Zhang JW; Zhao JY; Bai P; Zhang XC
Zhonghua Yi Xue Za Zhi; 2023 Apr; 103(16):1202-1209. PubMed ID: 37087403
[No Abstract] [Full Text] [Related]
19. Central nervous system metastases in patients with HER2-positive metastatic breast cancer: incidence, treatment, and survival in patients from registHER.
Brufsky AM; Mayer M; Rugo HS; Kaufman PA; Tan-Chiu E; Tripathy D; Tudor IC; Wang LI; Brammer MG; Shing M; Yood MU; Yardley DA
Clin Cancer Res; 2011 Jul; 17(14):4834-43. PubMed ID: 21768129
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer subtypes and outcomes of central nervous system metastases.
Arslan UY; Oksuzoglu B; Aksoy S; Harputluoglu H; Turker I; Ozisik Y; Dizdar O; Altundag K; Alkis N; Zengin N
Breast; 2011 Dec; 20(6):562-7. PubMed ID: 21871802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]